|
Contact: media@acc.org
Aspirin
and ACE Inhibitors Found Compatible
(Jun. 1, 1999) In recent years, aspirin and ACE inhibitors
have become widely popular for the treatment of a broad
range of cardiovascular conditions. Several studies,
however, have turned up surprising evidence that aspirin
may cause harmful effects in heart failure patients
who are taking ACE inhibitors, but no firm consensus
of opinion has emerged. Now, new data from a large study
from Israel offers some reassurance about the combination
of the two drugs. The Bezafibrate Infarction Prevention
(BIP) trial enrolled 11,575 patients with coronary artery
disease, of whom 1,247 were taking ACE inhibitors. Half
of these patients also took aspirin. BIP patients who
took aspirin and ACE inhibitors were less likely to
die than BIP patients who only took ACE inhibitors.
When the investigators only looked at the subset of
464 patients who had heart failure, use of aspirin in
combination with an ACE inhibitor was again found to
reduce the risk of death when compared to patients who
only took an ACE inhibitor. One possible difference
between the BIP study and previous studies is that patients
in the BIP trial took lower doses of aspirin (less than
250 mg per day) than patients in the other studies.
The American College of Cardiology, a 24,000-member
nonprofit professional medical society and teaching
institution, is dedicated to fostering optimal cardiovascular
care and disease prevention through professional education,
promotion of research, leadership in the development
of standards and guidelines, and the formulation of
health care policy.
The American College of Cardiology (ACC) provides these
news reports of clinical studies published in the Journal
of the American College of Cardiology as a service to
physicians, the media, the public, and other interested
parties. However, statements or opinions expressed in
these reports reflect the view of the author(s) and
do not represent official policy of the ACC unless stated
so.
Back
to June Releases
|